Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Sep 29 - Oct 4
Researchers are exploring its potential in metabolic health, longevity, and other cellular processes in 2026
The cardiac intravenous program (RGN-352) was placed on FDA clinical hold in March 2011 and never enrolled patients
02 Review Candidacy Relevant health history, allergies, medications, and pregnancy or breastfeeding status may be reviewed before treatment
What are the alternative treatment options
US$ 21.46
US$ 25.44
US$ 24.55
US$ 21.37
US$ 21.45
US$ 20.85
